-

Cresco Labs Opens Second Sunnyside in Miami, Florida

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced it has expanded in Miami, Florida, with the addition of a second store on the west side located at 8717 SW 24th St. The Company’s Florida retail footprint has grown to 29 total dispensaries. Nationwide, Cresco has 64 operating locations.

“We’re continuing our Florida expansion effort to bring our highly productive retail model and differentiated portfolio of branded products to more patients living in populous regions,” said Charlie Bachtell, Cresco Labs’ CEO & Co-Founder. “Miami-Dade is the eighth most populous U.S. county, with nearly 2.7 million residents, and we look forward to our new Westchester store joining our existing west Miami store to better serve the growing patient base in South Florida. We’re excited to add our newest Sunnyside store to our growing store network.”

Like Sunnyside’s other Florida stores, this new location will provide a wide assortment of cannabis products from the Company’s branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. The store also has a curated selection of accessories.

Patients can place orders today both in store and online through the retailer’s Sunnyside.shop website. Store hours are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

For more information, visit www.Sunnyside.shop.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com

Facebook: Cresco Labs
Twitter: Cresco Labs
LinkedIn: Cresco Labs

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Cresco Labs

CNSX:CL

Release Summary
Cresco Labs Opens Second Sunnyside in Miami, Florida
Release Versions

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Social Media Profiles
More News From Cresco Labs

Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced that it has filed a supplement (the "Supplement") to its management information circular dated September 18, 2026 (the "Circular") in connection with its annual general and special meeting of shareholders to be held on October 30, 2026. The Supplement enhances and clarifies the disclosure in the Circular concerning the proposed amendment to Cresco's super-voting shares a...

Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced that it has filed its Management Information Circular (the "Circular") and related proxy materials for its annual general and special meeting of shareholders to be held on October 30, 2026 (the “Meeting”), as it prepares for a potential listing on a senior U.S. exchange. At the Meeting, shareholders will be asked to approve three special resolutions relating to: (1) a...

Cresco Labs Appoints Edward Tilly to Board of Directors

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the appointment of Edward Tilly to its Board of Directors, effective September 18, 2026. Mr. Tilly will serve as an independent director and join the Audit Committee, bringing the Board to eight directors. Mr. Tilly is a financ...
Back to Newsroom